EU MSC2 2015: Contributing to MSC Knowledge-Sharing, Research & Development

Our sister project REDDSTAR and Leiden University Medical Center are co-organizing EU MSC2 2015, a meeting in Leiden, NL on September 7th and 8th to bring together nine EU-funded, mesenchymal stromal cell-focussed consortia. Projects include: REDDSTAR, REACH, RETHRIM, Stellar, MERLIN, Nephstrom, SCIENCE, VISICORT and Adipoa-2. This two day, interactive meeting will be held at the Stadsgehoorzaal Leiden.
The objectives of the meeting are to:
• Enhance knowledge-sharing between EU research groups working in the mesenchymal stromal cell biology domain
• Engage with European Commission Project Officers and other stakeholders from International Society of Cellular Therapy, stem cell ethicists and the European Medicines Agency (EMA)
• Assemble trans-disciplinary research groups working across the global health spectrum but with a common focus of mesenchymal stromal cell biology
• Bring up-and-coming researchers together for networking purposes, and to explore future consortium building and international funding application opportunities

Expected impacts and outcomes:
• Provide opportunities to develop new mesenchymal stromal cell networks
• Disseminate the findings and challenges between MSC-focussed consortia
• Improve the communication potential of research, outcomes and the value of the research
• Explore potential for new commercial technologies
• Collectively enhance the quality and impact of planned clinical trials
These EU projects are:
• Boosting human capital: 20-30 positions created
• Improving the quality of life for European citizens
• Progressing the clinical translation of MSC research and developments

For more information, please visit EU MSC2 2015 and register via Eventbrite.
For queries:
Danielle Nicholson, Orbsen Therapeutics, NUI Galway and Brigitte Wieles, Project Manager LUMC